Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells
Bo Chen(Zunyi Medical University), Jianqing Wu(Nanjing Medical University)
Cited by 32
Related Papers
Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549
|Journal of Experimental & Clinical Cancer Research|2010|109
Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib
|Cell & Bioscience|2015|50
YAP manipulates proliferation via PTEN/AKT/mTOR-mediated autophagy in lung adenocarcinomas
|Cancer Cell International|2021|41
TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription
|Cell Death and Disease|2019|27